These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 21195172)

  • 41. Assuring safety without animal testing: Unilever's ongoing research programme to deliver novel ways to assure consumer safety.
    Westmoreland C; Carmichael P; Dent M; Fentem J; MacKay C; Maxwell G; Pease C; Reynolds F
    ALTEX; 2010; 27(3):61-5. PubMed ID: 21113564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1.2 Aspects of test assessment.
    Hoffmann S
    Hum Exp Toxicol; 2009 Feb; 28(2-3):95-6. PubMed ID: 19713368
    [No Abstract]   [Full Text] [Related]  

  • 43. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence-based toxicology: strait is the gate, but the road is worth taking.
    Silbergeld E; Scherer RW
    ALTEX; 2013; 30(1):67-73. PubMed ID: 23338807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The future of regulatory toxicology: impact of the biotechnology revolution.
    MacGregor JT
    Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation and evolving science: neurobehavioral toxicology.
    Buckholtz NS; Panem S
    Neurobehav Toxicol Teratol; 1986; 8(1):89-96. PubMed ID: 3703099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 52. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).
    Rovida C; Hartung T
    ALTEX; 2009; 26(3):187-208. PubMed ID: 19907906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational chemistry, systems biology and toxicology. Harnessing the chemistry of life: revolutionizing toxicology. a commentary.
    Kimber I; Humphris C; Westmoreland C; Alepee N; Negro GD; Manou I
    J Appl Toxicol; 2011 Apr; 31(3):206-9. PubMed ID: 21404310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The great primate debate.
    Goodman S; Check E
    Nature; 2002 Jun; 417(6890):684-7. PubMed ID: 12066153
    [No Abstract]   [Full Text] [Related]  

  • 56. Developmental toxicity testing for safety assessment: new approaches and technologies.
    Knudsen TB; Kavlock RJ; Daston GP; Stedman D; Hixon M; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):413-20. PubMed ID: 21770025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicity testing: creating a revolution based on new technologies.
    Bhogal N; Grindon C; Combes R; Balls M
    Trends Biotechnol; 2005 Jun; 23(6):299-307. PubMed ID: 15922082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The utility of the minipig as an animal model in regulatory toxicology.
    Bode G; Clausing P; Gervais F; Loegsted J; Luft J; Nogues V; Sims J;
    J Pharmacol Toxicol Methods; 2010; 62(3):196-220. PubMed ID: 20685310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Has Toxicity Testing Moved into the 21st Century? A Survey and Analysis of Perceptions in the Field of Toxicology.
    Zaunbrecher V; Beryt E; Parodi D; Telesca D; Doherty J; Malloy T; Allard P
    Environ Health Perspect; 2017 Aug; 125(8):087024. PubMed ID: 28934728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Data gaps threaten chemical safety law.
    Gilbert N
    Nature; 2011 Jul; 475(7355):150-1. PubMed ID: 21753825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.